# Ispire Technology Inc.: overview ISPR · Nasdaq · CIK 1948455 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/ispr.md) · [Financials](/companies/ispr/financials.md) · [Filings](/companies/ispr/filings.md) · [Insiders](/companies/ispr/insiders.md) Latest reported revenue: [$26.7m](/filings/0001213900-26-100146.md) for Q4 FY2026, three months to 2026-06-30, from the 10-K filed Sep 15, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-100146). ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [39.3](/filings/0001213900-25-107205.md) | [41.8](/filings/0001213900-26-013305.md) | [26.2](/filings/0001213900-26-053368.md) | [20.1 d](/filings/0001213900-26-100146.md) | [30.4](/filings/0001213900-25-107205.md) | [20.3](/filings/0001213900-26-013305.md) | [18.7](/filings/0001213900-26-053368.md) | [26.7 d](/filings/0001213900-26-100146.md) | | Gross margin | % | [19.5%](/filings/0001213900-25-107205.md) | [18.5%](/filings/0001213900-26-013305.md) | [18.2%](/filings/0001213900-26-053368.md) | [12.3% d](/filings/0001213900-26-100146.md) | [17.0%](/filings/0001213900-25-107205.md) | [17.1%](/filings/0001213900-26-013305.md) | [10.7%](/filings/0001213900-26-053368.md) | [6.3% d](/filings/0001213900-26-100146.md) | | Operating margin | % | [(13.4%)](/filings/0001213900-25-107205.md) | [(17.6%)](/filings/0001213900-26-013305.md) | [(40.4%)](/filings/0001213900-26-053368.md) | [(72.7%) d](/filings/0001213900-26-100146.md) | [(8.9%)](/filings/0001213900-25-107205.md) | [(33.9%)](/filings/0001213900-26-013305.md) | [(50.8%)](/filings/0001213900-26-053368.md) | [(50.7%) d](/filings/0001213900-26-100146.md) | | Net margin | % | [(14.2%)](/filings/0001213900-25-107205.md) | [(19.1%)](/filings/0001213900-26-013305.md) | [(41.5%)](/filings/0001213900-26-053368.md) | [(73.4%) d](/filings/0001213900-26-100146.md) | [(10.7%)](/filings/0001213900-25-107205.md) | [(32.5%)](/filings/0001213900-26-013305.md) | [(51.0%)](/filings/0001213900-26-053368.md) | [(51.8%) d](/filings/0001213900-26-100146.md) | | Diluted EPS | $ per share | [(0.10)](/filings/0001213900-25-107205.md) | [(0.14)](/filings/0001213900-26-013305.md) | [(0.19)](/filings/0001213900-26-053368.md) | not reported | [(0.06)](/filings/0001213900-25-107205.md) | [(0.12)](/filings/0001213900-26-013305.md) | [(0.17)](/filings/0001213900-26-053368.md) | not reported | | Free cash flow | $m | [3.3](/filings/0001213900-25-107205.md) | [(3.2) d](/filings/0001213900-26-013305.md) | [(12.7) d](/filings/0001213900-26-053368.md) | [3.7 d](/filings/0001213900-26-100146.md) | [(1.2)](/filings/0001213900-25-107205.md) | [(4.0) d](/filings/0001213900-26-013305.md) | [1.7 d](/filings/0001213900-26-053368.md) | [2.6 d](/filings/0001213900-26-100146.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [88.1](/filings/0001213900-23-077437.md) | [116](/filings/0001213900-24-082378.md) | [152](/filings/0001213900-25-087632.md) | [127](/filings/0001213900-26-100146.md) | [96.0](/filings/0001213900-26-100146.md) | | Gross margin | % | [15.1%](/filings/0001213900-23-077437.md) | [18.0%](/filings/0001213900-24-082378.md) | [19.6%](/filings/0001213900-25-087632.md) | [17.8%](/filings/0001213900-26-100146.md) | [12.8%](/filings/0001213900-26-100146.md) | | Operating margin | % | [(1.1%)](/filings/0001213900-23-077437.md) | [(3.9%)](/filings/0001213900-24-082378.md) | [(9.1%)](/filings/0001213900-25-087632.md) | [(29.7%)](/filings/0001213900-26-100146.md) | [(33.9%)](/filings/0001213900-26-100146.md) | | Net margin | % | [(2.1%)](/filings/0001213900-23-077437.md) | [(5.2%)](/filings/0001213900-24-082378.md) | [(9.7%)](/filings/0001213900-25-087632.md) | [(30.8%)](/filings/0001213900-26-100146.md) | [(34.6%)](/filings/0001213900-26-100146.md) | | Diluted EPS | $ per share | [(0.04)](/filings/0001213900-23-077437.md) | [(0.12)](/filings/0001213900-24-082378.md) | [(0.27)](/filings/0001213900-25-087632.md) | [(0.69)](/filings/0001213900-26-100146.md) | [(0.58)](/filings/0001213900-26-100146.md) | | Free cash flow | $m | [(7.7)](/filings/0001213900-23-077437.md) | [(9.5)](/filings/0001213900-24-082378.md) | [(20.3)](/filings/0001213900-25-087632.md) | [(8.5)](/filings/0001213900-26-100146.md) | [(0.9)](/filings/0001213900-26-100146.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ispr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Yong Rong (HK) Asset Management Ltd](/funds/1738071.md) | 2026-06-30 | $1.7m | 1,504,147 | | Added +91 | | [Potomac Capital Management, Inc.](/funds/1418746.md) | 2026-06-30 | $670.4k | 598,600 | | New +598,600 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $458.8k | 409,610 | | Reduced −846,716 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $291.9k | 260,486 | | Reduced −236,001 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $291.2k | 260,041 | | New +260,041 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $221.5k | 197,724 | | Reduced −810 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $160.8k | 143,550 | | Added +76,233 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $142.7k | 127,445 | | New +127,445 | | [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $118.6k | 105,896 | | Added +53,677 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $113.2k | 101,035 | | Reduced −15,853 | ## Recent filings [All 176 filings](/companies/ispr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-23 | 21:34 ET | [8-K](/filings/0001213900-26-102333.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-102333 | | 2026-09-17 | 06:30 ET | [8-K](/filings/0001213900-26-100709.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-100709 | | 2026-09-15 | 16:30 ET | [10-K](/filings/0001213900-26-100146.md) | Annual report, period 2026-06-30 | 0001213900-26-100146 | | 2026-08-17 | 08:00 ET | [8-K](/filings/0001213900-26-090494.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-090494 | | 2026-07-17 | 16:30 ET | [8-K](/filings/0001213900-26-079192.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-079192 | | 2026-06-25 | 17:20 ET | [8-K](/filings/0001213900-26-072149.md) | 5.07 Shareholder vote results | 0001213900-26-072149 | | 2026-05-12 | 16:30 ET | [DEF 14A](/filings/0001213900-26-055113.md) | Proxy statement, period 2026-06-23 | 0001213900-26-055113 | | 2026-05-07 | 16:31 ET | [10-Q](/filings/0001213900-26-053368.md) | Quarterly report, period 2026-03-31 | 0001213900-26-053368 | | 2026-02-06 | 16:30 ET | [10-Q](/filings/0001213900-26-013305.md) | Quarterly report, period 2025-12-31 | 0001213900-26-013305 | | 2025-11-06 | 16:31 ET | [10-Q](/filings/0001213900-25-107205.md) | Quarterly report, period 2025-09-30 | 0001213900-25-107205 | ## Latest annual report [Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001213900-26-100146.md), filed Sep 15, 2026. ## Forecast league Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/8096b3e2-8d8a-4aa9-9bb4-93fa4c8f354f) ## About the filer - CIK: 1948455 - Tickers: ISPR - Exchange: Nasdaq - SIC code: 2111 Cigarettes - State of incorporation: not reported - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.